How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
O'Neil Sterile Field Intermittent Urinary Catheter (ONS) Market
- By Product Type: Hydrophilic Catheters, Pre-lubricated Catheters, Non-lubricated Catheters, Silicone Catheters, Latex Catheters
- By Material: Silicone, Latex, Polyurethane, PVC
- By Catheter Size (French): 12 Fr, 14 Fr, 16 Fr, 18 Fr, 20 Fr
- By User Type: Adult, Pediatric
- By Packaging Type: Individually Wrapped Sterile, Multi-pack Sterile
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Hydrophilic Catheters leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 289 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.174 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.182 →
Full report · locked preview
Everything inside the O'Neil Sterile Field Intermittent Urinary Catheter (ONS) Market report
A complete, evidence-based study - 12 chapters and 121 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Product Type 5
Material 4
Catheter Size (French) 5
User Type 2
Packaging Type 2
Companies profiled
Coloplast
Teleflex Incorporated
Becton Dickinson and Company (BD)
Hollister Incorporated
C.R. Bard (now part of BD)
Medtronic
Cook Medical
Rusch (Teleflex brand)
Nobel Medical
Dukal Corporation
Bard Medical
ConvaTec
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Coloplast
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Teleflex Incorporated
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Becton Dickinson and Company (BD)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Hollister Incorporated
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →C.R. Bard (now part of BD)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Medtronic
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Cook Medical
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Rusch (Teleflex brand)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Nobel Medical
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Dukal Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Bard Medical
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →ConvaTec
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →MediPro Medical
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Amsino International
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Bard Access Systems
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$8,893M by 2033 · 9.1% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Hydrophilic Catheters49.7
- Pre-lubricated Catheters14.8
- Non-lubricated Catheters7.6
- Silicone Catheters14.4
- Latex Catheters13.5
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,467M → $2,955M · 9.1%
Europe$1,023M → $1,964M · 8.5%
Asia Pacific$933.6M → $1,703M · 7.8%
Latin America$578.0M → $1,262M · 10.3%
Middle East and Africa$444.6M → $937.0M · 9.8%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →9.012026
9.022027
9.032028
9.052029
9.052030
9.072031
9.072032
9.082033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Coloplast28.9
- Teleflex Incorporated17.4
- Becton Dickinson and Company (BD)4.3
- Hollister Incorporated5.3
- C.R. Bard (now part of BD)5.3
- Medtronic10.8
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type19.9%
Material11.8%
Catheter Size (French)10.2%
User Type27.6%
Packaging Type30.5%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.5
- Europe22.3
- Asia Pacific19.3
- Latin America14.3
- Middle East and Africa10.6
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Coloplast | 95 | 74 | 95 | 76 | 87 | 97 | 87 |
| Teleflex Incorporated | 70 | 75 | 92 | 69 | 78 | 91 | 79 |
| Becton Dickinson and Company (BD) | 71 | 82 | 88 | 87 | 82 | 82 | 82 |
| Hollister Incorporated | 75 | 63 | 76 | 81 | 81 | 74 | 75 |
| C.R. Bard (now part of BD) | 54 | 56 | 62 | 56 | 58 | 58 | 57 |
| Medtronic | 62 | 62 | 65 | 71 | 52 | 57 | 62 |
| Cook Medical | 63 | 43 | 60 | 53 | 53 | 64 | 56 |
| Rusch (Teleflex brand) | 37 | 48 | 59 | 54 | 60 | 45 | 51 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Coloplast
- Teleflex Incorporated
- Becton Dickinson and Company (BD)
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Coloplast | ✓ | ✓ | ◐ | ✓ | ◐ | ✓ |
| Teleflex Incorporated | − | ◐ | ✓ | − | ◐ | ✓ |
| Becton Dickinson and Company (BD) | ◐ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Hollister Incorporated | ✓ | ✓ | ◐ | ◐ | ◐ | ◐ |
| C.R. Bard (now part of BD) | ◐ | ◐ | − | − | ◐ | − |
| Medtronic | − | − | ◐ | ✓ | − | − |
| Cook Medical | ◐ | ◐ | ◐ | ◐ | ◐ | − |
| Rusch (Teleflex brand) | − | − | ◐ | ◐ | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Coloplast87
2Becton Dickinson and Company (BD)82
3Teleflex Incorporated79
4Hollister Incorporated75
5Medtronic62
6C.R. Bard (now part of BD)57
7Cook Medical56
8Rusch (Teleflex brand)51
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
ColoplastTeleflex IncorporatedBecton Dickinson and Company (BD)
Challenger1
Strong scale, closing on the leaders.
Hollister Incorporated
Contender2
Focused players with pockets of strength.
C.R. Bard (now part of BD)Medtronic
Niche2
Specialists in a single segment or region.
Cook MedicalRusch (Teleflex brand)
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across O'Neil Sterile Field Intermittent Urinary Catheter (ONS) Market — a $386M beachhead inside a $6.46B market.
Beachhead (SOM)$386Mobtainable near-term
Serviceable (SAM)$2.23Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale3 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion91 fit
Hydrophilic Catheters
Best fit — highest urgency & budget in Product Type.
Economic buyer81 fit
Pre-lubricated Catheters
Strong fit — clear ROI and a fast path to value.
End user65 fit
Non-lubricated Catheters
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Material & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Catheter Size (French)
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales41%
Partner / channel29%
Digital / self-serve23%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win O'Neil Sterile Field Intermittent Urinary Catheter (ONS) Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified39%
Sales qualified22%
Evaluation15%
Closed-won6%
$16.3KCAC
$65KLTV
4.0:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
O'Neil Sterile Field Intermittent Urinary Catheter (ONS) Market is a resilient opportunity — $3.69B by 2033, compounding at 3.8%.
TAM · 2025$2.73Btoday
TAM · 2033$3.69Bforecast
CAGR3.8%2027–2033
Cumulative$28.7Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$3.69BTotal addressable market
SAM$1.42BServiceable available market
SOM$240MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →3.8% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$3.69BLarge & growingTAM by 2033 at 3.8% CAGR
$1.42BServiceable nowreachable with today’s model
$240MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$2.88BBear2.5% CAGR
$3.69BBase3.8% CAGR
$4.72BBull5.0% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Material optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
O'Neil Sterile Field Intermittent Urinary Catheter (ONS) Market — a $2.38B market by 2033. Plan: grow share from 10.6% to 18.0%.
Market size · 2033$2.38Btotal addressable
Market CAGR10.6%2027–2033
Target share18.0%from 10.6% today
Revenue ambition$428Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 10.6% | 18.0% | At risk |
| Revenue | $251M | $428M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Ahead |
| Gross margin | 31.6% | 43.9% | On track |
| Customer retention | 89.5% | 94.4% | Ahead |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Material capability
A defensible second engine — invest in Material to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Material
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $49M capacity & capability investment
- Greenlight bolt-on M&A in Material
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossOn track
- Input-cost & supply riskBehind
- Regulatory / policy changeOn track
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the O'Neil Sterile Field Intermittent Urinary Catheter (ONS) Market conversation — a $8.87B market you can size, segment and defend in minutes.
Market size · 2033$8.87Btotal opportunity
Growth10.1%CAGR to 2033
Addressable buyers1,380+accounts in scope
Typical ROI6.3×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.3×return on cost, year one
< 2 mopayback period
$91K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
ColoplastTeleflex IncorporatedBecton Dickinson and Company (BD)Hollister IncorporatedC.R. Bard (now part of BD)MedtronicCook MedicalRusch (Teleflex brand)+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your O'Neil Sterile Field Intermittent Urinary Catheter (ONS) Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
O'Neil Sterile Field Intermittent Urinary Catheter (ONS) Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Angiography Instrument Kit Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportSurgical Gowns and Helmets Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportAngiography Imaging Systems Market
Market size, share, segmentation and regional forecast.
$1.7B market · 2025 base year
View reportObstetrics Devices Market
Market size, share, segmentation and regional forecast.
$4.0B market · 2025 base year
View reportAdvanced CT Visualization Systems Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportAngiography Device Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportMedical Imaging Cameras Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportAngiography Consumable Market
Market size, share, segmentation and regional forecast.
$508M market · 2025 base year
View reportCOPD Drug Delivery Devices Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportAngiographic Needles Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportMedical Laminations Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportAngiographic Kits Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.